Claire Mulot Selected Research

Cetuximab (Erbitux)

12/2018	Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
10/2018	Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claire Mulot Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 05/2010
9	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 05/2010
8	Breast Neoplasms (Breast Cancer) 01/2023 - 10/2012
3	Colonic Neoplasms (Colon Cancer) 10/2021 - 10/2018
3	Parkinson Disease (Parkinson's Disease) 01/2018 - 08/2012
2	Carcinogenesis 01/2023 - 01/2019
2	Adenocarcinoma 01/2022 - 10/2020
2	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 10/2019
1	Colitis 01/2023
1	Ulcerative Colitis 01/2023
1	Hypoxia (Hypoxemia) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Genetic Risk Score 01/2020
1	Microsatellite Instability 12/2018
1	Neuroinflammatory Diseases 11/2017
1	Neoplasm Metastasis (Metastasis) 11/2015
1	Exanthema (Rash) 01/2008
1	Eosinophilia 01/2008

Drug/Important Bio-Agent (IBA)

6	Estrogen ReceptorsIBA 01/2023 - 10/2012
6	Circulating Tumor DNAIBA 01/2022 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	AnthracyclinesIBA 01/2021 - 11/2015
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021 - 11/2015
2	LigandsIBA 01/2021 - 11/2015
2	Prion ProteinsIBA 01/2021 - 08/2019
2	ORALIT (ORS)IBA 12/2020 - 10/2019
2	XenobioticsIBA 01/2019 - 01/2018
2	Cetuximab (Erbitux)FDA Link 12/2018 - 10/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2018 - 05/2010
2	HLA-DRB1 Chains (HLA DRB1)IBA 11/2017 - 08/2012
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023
1	Detergents (Detergent)IBA 01/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	MutagensIBA 01/2023
1	Sulindac (Copal)FDA LinkGeneric 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	AzoxymethaneIBA 01/2023
1	cyclosporin HIBA 01/2023
1	chemotactic factor inactivatorIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	mahuang-tangIBA 01/2022
1	AntigensIBA 01/2022
1	CarbohydratesIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Poly I-CIBA 01/2021
1	Annexin A1IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	CarcinogensIBA 01/2021
1	eryaspaseIBA 10/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	SmokeIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Neuropeptide YIBA 01/2016
1	Therapeutic UsesIBA 11/2015
1	MicroRNAs (MicroRNA)IBA 01/2014
1	3' Untranslated Regions (3' UTR)IBA 01/2014
1	HLA-DR alpha-ChainsIBA 08/2012
1	HLA-DRB5 Chains (HLA DRB5)IBA 08/2012
1	Fluorouracil (Carac)FDA LinkGeneric 05/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2010
1	Minocycline (Cyclops)FDA LinkGeneric 01/2008

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2023 - 11/2015
3	Adjuvant Chemotherapy 12/2018 - 11/2015
1	Chemoradiotherapy 01/2023
1	Therapeutics 01/2022
1	Duration of Therapy 10/2021
1	Immunotherapy 01/2021
1	Lab-On-A-Chip Devices 11/2015